Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $12.7 million.

  • Icu Medical's Change in Receivables fell 3007.9% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.4 million, marking a year-over-year increase of 42587.13%. This contributed to the annual value of $46.8 million for FY2024, which is 19631.75% up from last year.
  • Icu Medical's Change in Receivables amounted to $12.7 million in Q3 2025, which was down 3007.9% from $5.7 million recorded in Q2 2025.
  • Over the past 5 years, Icu Medical's Change in Receivables peaked at $35.3 million during Q4 2024, and registered a low of -$82.0 million during Q1 2023.
  • In the last 5 years, Icu Medical's Change in Receivables had a median value of $3.7 million in 2023 and averaged -$17789.5.
  • Within the past 5 years, the most significant YoY rise in Icu Medical's Change in Receivables was 422220.28% (2022), while the steepest drop was 139329.35% (2022).
  • Over the past 5 years, Icu Medical's Change in Receivables (Quarter) stood at -$9.9 million in 2021, then surged by 202.48% to $10.2 million in 2022, then tumbled by 154.43% to -$5.5 million in 2023, then soared by 736.64% to $35.3 million in 2024, then tumbled by 63.91% to $12.7 million in 2025.
  • Its Change in Receivables was $12.7 million in Q3 2025, compared to $5.7 million in Q2 2025 and -$22.4 million in Q1 2025.